PRME (Prime Medicine) Total Liabilities: $218.03 Mil (As of Mar. 2026)


PRME Prime Medicine Inc PRME
25 GF Score
Price $3.26
! 4 Warning Signs
View Full Analysis

What is Prime Medicine Total Liabilities?

Prime Medicine PRME +2.68% 25 Total Liabilities is $218.03 Mil as of Mar. 2026. GuruFocus rates PRME with a GF Score™ of 25/100. The stock has 4 warning signs investors should review.

Prime Medicine's Total Liabilities for the quarter that ended in Mar. 2026 was $218.03 Mil.

Prime Medicine's quarterly Total Liabilities declined from Sep. 2025 ($223.19 Mil) to Dec. 2025 ($221.87 Mil) and declined from Dec. 2025 ($221.87 Mil) to Mar. 2026 ($218.03 Mil).

Prime Medicine's annual Total Liabilities increased from Dec. 2023 ($60.78 Mil) to Dec. 2024 ($144.36 Mil) and increased from Dec. 2024 ($144.36 Mil) to Dec. 2025 ($221.87 Mil).

Prime Medicine Total Liabilities Historical Data

* Premium members only.

The historical data trend for Prime Medicine's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prime Medicine Total Liabilities Chart

Prime Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 62.30 44.04 60.78 144.36 221.87

Prime Medicine Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 221.24 218.15 223.19 221.87 218.03
PRME
25GF Score
Prime Medicine Inc PRME
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prime Medicine Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Prime Medicine's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37.448+(108.29+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+76.127+0+0)
=221.87

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=342.733-120.868
=221.87

Prime Medicine's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=36.289+(105.966+-1.4210854715202E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+75.775+0+0)
=218.03

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=294.73-76.7
=218.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $218.03 Mil mean?
Prime Medicine (PRME) has a Total Liabilities of $218.03 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Prime Medicine and its competitors.
Is Prime Medicine's Total Liabilities too high?
Prime Medicine's current Total Liabilities is $218.03 Mil. Overall, Prime Medicine has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Prime Medicine's Total Liabilities compare to IMMX and SGP?
Prime Medicine's Total Liabilities of $218.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Prime Medicine and its competitors. Prime Medicine's current Total Liabilities is $218.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prime Medicine stock overvalued right now?
Prime Medicine (PRME) has a current Total Liabilities of $218.03 Mil. The current Total Liabilities is $218.03 Mil. Prime Medicine's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Prime Medicine (PRME), the current Total Liabilities is $218.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prime Medicine Business Description

Address 60 First Street, Cambridge, MA, USA, 02141
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
25GF Score

Get the complete analysis for PRME

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.26
Price